A detailed history of Destination Wealth Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Destination Wealth Management holds 7,012 shares of EW stock, worth $510,543. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,012
Previous 6,819 2.83%
Holding current value
$510,543
Previous $629,000 26.55%
% of portfolio
0.01%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

BUY
$59.7 - $93.78 $11,522 - $18,099
193 Added 2.83%
7,012 $462,000
Q2 2024

Jul 24, 2024

SELL
$84.3 - $94.31 $20,063 - $22,445
-238 Reduced 3.37%
6,819 $629,000
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $29,088 - $38,319
-401 Reduced 5.38%
7,057 $674,000
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $103,549 - $130,481
-1,678 Reduced 18.37%
7,458 $568,000
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $6,997 - $9,431
-101 Reduced 1.09%
9,136 $632,000
Q2 2023

Aug 11, 2023

SELL
$81.41 - $94.33 $34,192 - $39,618
-420 Reduced 4.35%
9,237 $871,000
Q1 2023

May 05, 2023

BUY
$74.26 - $84.51 $56,066 - $63,805
755 Added 8.48%
9,657 $798,000
Q4 2022

Feb 10, 2023

BUY
$68.3 - $87.44 $3,551 - $4,546
52 Added 0.59%
8,902 $664,000
Q3 2022

Nov 10, 2022

BUY
$82.37 - $107.29 $2,059 - $2,682
25 Added 0.28%
8,850 $731,000
Q2 2022

Jul 29, 2022

BUY
$86.5 - $128.27 $106,741 - $158,285
1,234 Added 16.26%
8,825 $839,000
Q1 2022

May 12, 2022

SELL
$101.96 - $128.34 $16,721 - $21,047
-164 Reduced 2.11%
7,591 $894,000
Q4 2021

Feb 04, 2022

SELL
$106.37 - $130.68 $1,382 - $1,698
-13 Reduced 0.17%
7,755 $1.01 Million
Q3 2021

Oct 25, 2021

BUY
$102.91 - $122.75 $20,993 - $25,041
204 Added 2.7%
7,768 $879,000
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $4,527 - $5,657
-54 Reduced 0.71%
7,564 $783,000
Q1 2021

May 05, 2021

SELL
$78.68 - $90.67 $10,779 - $12,421
-137 Reduced 1.77%
7,618 $637,000
Q4 2020

Feb 11, 2021

SELL
$71.69 - $91.23 $30,468 - $38,772
-425 Reduced 5.2%
7,755 $707,000
Q3 2020

Nov 12, 2020

SELL
$67.19 - $87.44 $144,525 - $188,083
-2,151 Reduced 20.82%
8,180 $653,000
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $378,210 - $505,792
6,573 Added 174.91%
10,331 $714,000
Q1 2020

May 13, 2020

SELL
$52.41 - $81.0 $4,350 - $6,723
-83 Reduced 2.16%
3,758 $709,000
Q4 2019

Feb 12, 2020

BUY
$71.7 - $82.09 $6,811 - $7,798
95 Added 2.54%
3,841 $896,000
Q3 2019

Nov 13, 2019

SELL
$61.55 - $75.43 $40,130 - $49,180
-652 Reduced 14.82%
3,746 $824,000
Q2 2019

Jul 19, 2019

BUY
$55.74 - $64.41 $48,995 - $56,616
879 Added 24.98%
4,398 $812,000
Q1 2019

May 01, 2019

BUY
$47.89 - $64.05 $2,107 - $2,818
44 Added 1.27%
3,519 $673,000
Q4 2018

Feb 05, 2019

BUY
$46.41 - $56.94 $90,592 - $111,146
1,952 Added 128.17%
3,475 $532,000
Q3 2018

Nov 07, 2018

BUY
$45.7 - $58.03 $66,676 - $84,665
1,459 Added 2279.69%
1,523 $265,000
Q2 2018

Jul 31, 2018

SELL
$42.45 - $51.3 $110,072 - $133,020
-2,593 Reduced 97.59%
64 $9,000
Q1 2018

Apr 05, 2018

BUY
$37.19 - $47.45 $98,813 - $126,074
2,657 New
2,657 $56,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Destination Wealth Management Portfolio

Follow Destination Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Destination Wealth Management with notifications on news.